RUNX2 was overexpressed in tissue samples of bladder urothelial cancer, and immunohistochemistry further demonstrated the positive correlation of high RUNX2 levels with cancer-associated fibroblast biomarkers [18]. This evidence concerns the gene RUNX2 and bladder transitional cell carcinoma.